International Journal of Drug Delivery Technology
Volume 15, Issue 2

Effect of Vortioxetine on Pilocarpine Induced Status Epilepticus in Sprague Dawley Rats 

Shreya Hegde1, Sharath Kumar C1, Amrita Parida1,2*, Jagnoor Singh Sandhu2,3, Manju V4

1Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India

2Center for Animal Research, Ethics and Training (CARET), Manipal Academy of Higher Education, Manipal, Karnataka-576104, India

3Central Animal Research Facility, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India

4Dr. TMA Pai Rotary Hospital, Karkala, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India 

Received: 12th Apr, 2025; Revised: 17th May, 2025; Accepted: 3rd Jun, 2025; Available Online: 25th Jun, 2025

ABSTRACT

Background: Status epilepticus (SE) is a frequently encountered medical emergency that may not respond to existing antiepileptic medications, underscoring the urgency for exploring alternative treatment options. Vortioxetine, a novel multimodal antidepressant, modulates several serotonin receptors and has shown anticonvulsant potential in other seizure models. However, its role in SE remains unexplored.

Objective: The study assessed the impact of vortioxetine on seizure severity, onset latency, and 24-hour survival in a rodent model of status epilepticus using lithium-pilocarpine.

Methods: Twenty-four male Sprague Dawley rats were randomized into four groups: (1) disease control (distilled water), (2) standard treatment (diazepam, 5 mg/kg), (3) vortioxetine 10 mg/kg, and (4) vortioxetine 20 mg/kg. All groups received lithium chloride and pilocarpine to induce SE. Modified Racine scale was used to score the seizure severity. Latency to stage 4 seizures and SE, seizure scores, and 24-hour survival rates were assessed. The mean differences between groups was analyzed by one-way ANOVA. This was followed by Tukey’s post hoc test to see the intergroup differences.

Results: All animals in the disease control and low-dose vortioxetine groups progressed to stage 5 seizures and SE, with 33.3% and 16.7% mortality, respectively. In the high-dose vortioxetine group, 83.3% developed SE with no mortality. Diazepam significantly delayed seizure onset, reduced severity, and prevented SE. Vortioxetine at both doses showed only marginal increases in seizure latency and no significant reduction in seizure severity or SE incidence compared to control.

Conclusion: Vortioxetine did not exhibit significant protective effects against lithium-pilocarpine-induced SE in Sprague Dawley rats at the doses tested. Its limited efficacy may be due to the complex pathophysiology of SE and the acute nature of the model. Further studies are warranted to explore its role in chronic epilepsy models or as adjunctive therapy.

Keywords: Vortioxetine, epilepsy, serotonin, pilocarpine model, anticonvulsant, rodent

How to cite this article: Shreya Hegde, Sharath Kumar C, Amrita Parida, Jagnoor Singh Sandhu, Manju V. Effect of Vortioxetine on Pilocarpine Induced Status Epilepticus in Sprague Dawley Rats. International Journal of Drug Delivery Technology. 2025;15(2):635-40. doi: 10.25258/ijddt.15.2.33

REFERENCES

  1. Leitinger M, Trinka E, Zimmermann G, Granbichler CA, Kobulashvili T, Siebert U. Epidemiology of status epilepticus in adults: Apples, pears, and oranges - A critical review. Epilepsy Behav. 2020 Feb;103(Pt A):106720. DOI: 10.1016/j.yebeh.2019.106720
  2. Guidelines for Epidemiologic Studies on Epilepsy: Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia. 1993 Jul;34(4):592–6. DOI: 10.1111/j.1528-1157.1993.tb00433.x
  3. Lowenstein DH, Bleck T, Macdonald RL. It’s Time to Revise the Definition of Status Epilepticus. Epilepsia. 1999 Jan;40(1):120–2. DOI: 10.1111/j.1528-1157.1999.tb02000.x
  4. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015 Oct;56(10):1515–23. DOI: 10.1111/epi.13121
  5. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010 Feb;51(2):251–6. DOI: 10.1111/j.1528-1167.2009.02323.x
  6. Tallarico M, Pisano M, Leo A, Russo E, Citraro R, De Sarro G. Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand? Curr Neuropharmacol. 2023;21(8):1691–713. DOI: 10.2174/1570159X20666220627160048
  7. Mazarati A, Siddarth P, Baldwin RA, Shin D, Caplan R, Sankar R. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain. 2008 Aug;131(Pt 8):2071–83. DOI: 10.1093/brain/awn117
  8. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia. 2007 Aug;48(8):1526–30. DOI: 10.1111/j.1528-1167.2007.01089.x
  9. Schönhoff K, von Rüden EL, Koska I, Seiffert I, Potschka H. Hippocampal and Septal 5-HT1A Receptor Expression in Two Rat Models of Temporal Lobe Epilepsy. Neuroscience. 2021 Jun 15;465:219–30. DOI: 10.1016/j.neuroscience.2021.03.026
  10. López-Meraz ML, Martínez A, Rocha L. Effect of 8-OH-DPAT on electrographic activity during the kainic acid-induced status epilepticus in rats. Seizure. 2007 Jun;16(4):365–70. DOI: 10.1016/j.seizure.2007.02.009
  11. Heydari A, Davoudi S. The effect of sertraline and 8-OH-DPAT on the PTZ_induced seizure threshold: Role of the nitrergic system. Seizure. 2017 Feb;45:119–24. DOI: 10.1016/j.seizure.2016.12.005
  12. Kruse SW, Dayton KG, Purnell BS, Rosner JI, Buchanan GF. Effect of monoamine reuptake inhibition and α1 blockade on respiratory arrest and death following electroshock-induced seizures in mice. Epilepsia. 2019 Mar;60(3):495–507. DOI: 10.1111/epi.14652
  13. Lin WH, Li XF, Lin MX, Zhou Y, Huang HP. Novel insights into the effect of paroxetine administration in pilocarpine‑induced chronic epileptic rats. Mol Med Rep. 2017 Dec;16(6):8245–52. DOI: 10.3892/mmr.2017.7659
  14. Ögün MN, Çetinkaya A, Beyazçiçek E. The effect of vortioxetine on penicillin-induced epileptiform activity in rats. Arq Neuropsiquiatr. 2019 Jul 15;77(6):412–7. DOI: 10.1590/0004-282X20190064
  15. Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2011 May 12;54(9):3206–21. DOI: 10.1021/jm101459g
  16. Chen G, Højer AM, Areberg J, Nomikos G. Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. Clin Pharmacokinet. 2018;57(6):673–86. DOI: 10.1007/s40262-017-0612-7
  17. Sowa-Kućma M, Pańczyszyn-Trzewik P, Misztak P, Jaeschke RR, Sendek K, Styczeń K, et al. Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant. Pharmacol Rep. 2017 Aug;69(4):595–601. DOI: 10.1016/j.pharep.2017.01.030
  18. Yang Z, Liu X, Yin Y, Sun S, Deng X. Involvement of 5-HT₇ receptors in the pathogenesis of temporal lobe epilepsy. Eur J Pharmacol. 2012 Jun 15;685(1–3):52–8. DOI: 10.1016/j.ejphar.2012.04.011
  19. Zheng Y, Moussally J, Cash SS, Karnam HB, Cole AJ. Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: Behavioral, physiological and histological studies. Neuropharmacology. 2010 Mar;58(4–5):793–8. DOI: 10.1016/j.neuropharm.2009.12.007
  20. Kumar C S, Patil N, Parida A, Kabirdev K, Priyadarshini P, Gurung S, et al. Effect of Vortioxetine on Maximal electroshock (MES) induced seizures in Sprague Dawley rats. RJPT. 2021 Aug 6;4337–40. DOI: 10.52711/0974-360X.2021.00753
  21. Joushi S, Salmani ME. Effect of eugenol on lithium-pilocarpine model of epilepsy: behavioral, histological, and molecular changes. Iran J Basic Med Sci. 2017 Jul;20(7):745–52.
  22. Taskiran M, Unal G. Vortioxetine suppresses epileptiform activity and cognition deficits in a chronic PTZ-induced kindling rat model. Epileptic Disord. 2021 Dec 1;23(6):893–900. DOI: 10.22038/IJBMS.2017.9004
  23. Aygun H, Ayyildiz M. Vortioxetine increases absence-like seizures in WAG/Rij rats but decreases penicillin- and pentylenetetrazole-induced seizures in Wistar rats. Epilepsy Behav. 2021 Mar;116:107797. DOI: 10.1016/j.yebeh.2021.107797
  24. Perucca E, Bialer M, White HS. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. CNS Drugs. 2023 Sep;37(9):755–79. DOI: 10.1007/s40263-023-01027-2
  25. Gilliam FG, Hecimovic H, Gentry MS. Serotonergic Therapy in Epilepsy. Curr Opin Neurol. 2021 Apr 1;34(2):206–12. DOI: 10.1097/WCO.0000000000000901
  26. Sánchez Fernández I, Goodkin HP, Scott RC. Pathophysiology of convulsive status epilepticus. Seizure. 2019 May;68:16–21. DOI: 10.1016/j.seizure.2018.08.002
  27. Siwek M, Gorostowicz A, Bosak M, Dudek D. Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy-Case Series. Front Pharmacol. 2022;13:852042. DOI: 10.3389/fphar.2022.852042